Sorkhi Hadi, Behzadi Raheleh, Joghtaei Neda, Poornasrollah Mohammad, Bijani Ali
Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
Caspian J Intern Med. 2018 Summer;9(3):290-295. doi: 10.22088/cjim.9.3.290.
Measurement of glomerular filtration rate (GFR) and monitoring of it in any patient on nephrotoxic drugs is very important. Recently, cystatin C (cys-C) has been introduced as a better marker for determining and monitoring renal function than creatinine especially in a mild decrease of GFR. This study was done to assess the change of GFR measurement based on serum Cys-C and creatinine and their comparison in children with acute pyelonephritis on amikacin.
All children with acute pyelonephritis who were admitted in Nephrology ward were enrolled in this study. Serum creatinine, serum cys-C and the GFR calculation based on them were measured in patients on the day of admission (day zero) and then on days 3 and 7 after the start of treatment with amikacin and p-value less than 0.05 was considered significant.
Among the 70 children, 61 patients were females and the others were males. Mean age was 42.66±41.53 months. Estimated GFR based on creatinine on day 0 (before amikacin administration), 3 and 7 were 72.41±20.89 ml/min/1.73 m, 78.42±21.15 ml/min/1.73 m and 80.5±22.43 ml/min/1.73 m, respectively. Moreover, GFR based on cys-C during these days were 116.23±58.9 ml/min/1.73 m, 116.49±53.31 ml/min/1.73 m and 108.37±51.02 ml/min/1.73 m, respectively (p<0.05).
According to this study, decrease of GFR calculation based on Cys-C was seen and estimated GFR was not changed according to creatinine. So, we recommend the use of cys-C for the monitoring of renal function in any patient treated with nephrotoxic drugs such as amikacin.
对于任何正在使用肾毒性药物的患者,测量肾小球滤过率(GFR)并对其进行监测非常重要。最近,胱抑素C(cys-C)已被引入,作为一种比肌酐更好的用于测定和监测肾功能的标志物,尤其是在GFR轻度下降的情况下。本研究旨在评估基于血清胱抑素C和肌酐的GFR测量变化及其在使用阿米卡星治疗的急性肾盂肾炎儿童中的比较。
所有入住肾病病房的急性肾盂肾炎儿童均纳入本研究。在入院当天(第0天)以及开始使用阿米卡星治疗后的第3天和第7天,测量患者的血清肌酐、血清胱抑素C以及基于它们计算的GFR,p值小于0.05被认为具有统计学意义。
70名儿童中,61名为女性,其余为男性。平均年龄为42.66±41.53个月。基于肌酐在第0天(阿米卡星给药前)、第3天和第7天估算的GFR分别为72.41±20.89 ml/min/1.73 m²、78.42±21.15 ml/min/1.73 m²和80.5±22.43 ml/min/1.73 m²。此外,这些天基于胱抑素C的GFR分别为116.23±58.9 ml/min/1.73 m²、116.49±53.31 ml/min/1.73 m²和108.37±51.02 ml/min/1.73 m²(p<0.05)。
根据本研究,基于胱抑素C计算的GFR出现下降,而基于肌酐估算的GFR未发生变化。因此,我们建议在任何接受如阿米卡星等肾毒性药物治疗的患者中使用胱抑素C来监测肾功能。